Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Nephros Q2 EPS $0.02 Beats $(0.03) Estimate, Sales $4.42M Beat $3.65M Estimate

Author: Benzinga Newsdesk | August 07, 2025 04:01pm
Nephros (NASDAQ:NEPH) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.03) by 180 percent. This is a 166.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $4.42 million which beat the analyst consensus estimate of $3.65 million by 21.04 percent. This is a 35.89 percent increase over sales of $3.25 million the same period last year.

Posted In: NEPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist